Nexium (Esomeprazole)

Esomeprazole, the active ingredient in Nexium, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is prescribed for conditions such as gastro‑oesophageal reflux disease and related acid‑related disorders.

GNH USA supplies Nexium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Esomeprazole is a proton pump inhibitor used to manage acid‑related gastrointestinal conditions.

- Gastro‑oesophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of the esophageal lining. - Erosive oesophagitis: facilitates mucosal repair by lowering gastric acidity. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors. - Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotic regimens by creating a less acidic gastric environment.

Common side effects are generally mild and transient.

Common Side Effects: - Headache: mild to moderate pain often resolving without intervention. - Diarrhea: loose stools that may improve with continued therapy. - Nausea: feeling of queasiness, usually transient. - Abdominal pain: discomfort in the stomach region. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Clostridioides difficile infection: severe diarrhea with possible colitis. - Elevated liver enzymes: signs of hepatic stress. - Hypomagnesemia: low magnesium levels, potentially causing muscle cramps. - Stevens‑Johnson syndrome: rare skin blistering condition. - Acute pancreatitis: inflammation of the pancreas presenting with abdominal pain.

Before initiating therapy, consider the following safety measures.

- Assess renal function: adjust use in patients with severe impairment. - Monitor for infection: increased risk of Clostridioides difficile colitis. - Avoid prolonged use without review: potential for nutrient malabsorption (e.g., vitamin B12, calcium). - Use caution in pregnancy: discuss risks and benefits with a healthcare professional. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Esomeprazole may alter the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid): - Ketoconazole: reduced absorption leading to decreased antifungal efficacy. - Atazanavir: decreased antiviral levels, compromising HIV therapy. - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Warfarin: possible increase in INR, enhancing bleeding risk. - Methotrexate: increased toxicity due to reduced clearance.

Moderate Interactions (Monitor Closely): - Digoxin: elevated serum concentrations, requiring level monitoring. - Diazepam: enhanced sedation, may need dose adjustment. - Theophylline: increased plasma levels, risk of toxicity. - HIV protease inhibitors: altered exposure, may affect viral suppression. - Iron supplements: decreased iron absorption, consider spacing administration.